EGenesis

egenesisbio.com

EGenesis is a biotechnology company focused on addressing the global transplant shortage through innovative solutions in organ and cell transplantation. Utilizing its EGEN Platform, the company leverages advanced gene editing technologies to develop human-compatible organs and cells, particularly targeting kidney and islet cell transplantation. With a mission to transform the treatment of organ failure, EGenesis aims to improve patient outcomes and reduce the number of individuals waiting for transplants. The company is positioned at the forefront of xenotransplantation research, addressing a critical need in the healthcare market.